SEC Form 4 · accession 0001144204-15-067076
Cellectar Biosciences, Inc. · CLRB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James V Caruso
Officer — President and CEO · Director
Period of report
Nov 18, 2015
Accepted (ET)
Nov 19, 2015 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001279704
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share | Nov 18, 2015 | P | 2,000 | $1.3949 | A | 2,000 | D | |
| Common Stock, par value $0.00001 per share | Nov 19, 2015 | P | 2,000 | $1.50 | A | 4,000 | D |
Table II — derivative securities
No Table II lines on this filing.